These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 1083506)
21. [Physiological review of hemostasis]. Launay F Neurochirurgie; 1973; 19(3):259-64. PubMed ID: 4547605 [No Abstract] [Full Text] [Related]
22. Letter: Inhibition of ristocetin-induced platelet aggregation by haemaccel. Stibbe J; Kirby EP Br Med J; 1975 Jun; 2(5973):750-1. PubMed ID: 1079739 [No Abstract] [Full Text] [Related]
23. [Studies on the effects of five monoclonal antibodies, polyclonal rabbit antibody and homologous antibody to human F VIII/vWF on ristocetin-induced platelet agglutination and platelet retention by glass bead column]. Ogata K; Minami S; Kamiya T Rinsho Ketsueki; 1985 Jul; 26(7):1042-9. PubMed ID: 2414486 [No Abstract] [Full Text] [Related]
24. Detection of an acquired platelet storage pool disease in three patients with a myeloproliferative disorder. Rendu F; Lebret M; Nurden A; Caen JP Thromb Haemost; 1979 Aug; 42(2):794-6. PubMed ID: 505381 [No Abstract] [Full Text] [Related]
25. Low shear stress can initiate von Willebrand factor-dependent platelet aggregation in patients with type IIB and platelet-type von Willebrand disease. Murata M; Fukuyama M; Satoh K; Fujimura Y; Yoshioka A; Takahashi H; Handa M; Kawai Y; Watanabe K; Ikeda Y J Clin Invest; 1993 Sep; 92(3):1555-8. PubMed ID: 8376606 [TBL] [Abstract][Full Text] [Related]
26. Sebastian syndrome with abnormal platelet response to ristocetin. Redman R; Shunkwiler SM; Harris NS; Kedar A; Clapp WL Lab Hematol; 2008; 14(3):19-23. PubMed ID: 18812282 [TBL] [Abstract][Full Text] [Related]
28. [Type 2B and pseudo type 2B Von Willebrand disease; a report of three cases]. Guermazi S; Conard J; Samama MM; Dellagi K Pathol Biol (Paris); 2006 Apr; 54(3):159-65. PubMed ID: 16176858 [TBL] [Abstract][Full Text] [Related]
29. [Hemostasis disorders and their treatment in patients with chronic myeloproliferative diseases]. Sidorova LD; Arkhipov BF; Degtiareva MM; Barkagan LZ Ter Arkh; 1981; 53(9):91-5. PubMed ID: 7302866 [No Abstract] [Full Text] [Related]
30. Bleeding and thrombosis in chronic myeloproliferative disorders: relation of platelet disorders to clinical aspects of the disease. Wehmeier A; Scharf RE; Fricke S; Schneider W Haemostasis; 1989; 19(5):251-9. PubMed ID: 2777137 [TBL] [Abstract][Full Text] [Related]
31. Agglutination of formalin-fixed, platelet-type von Willebrand's disease platelets by human von Willebrand factor. Takahashi H; Shibata A Thromb Haemost; 1984 Dec; 52(3):267-70. PubMed ID: 6241752 [TBL] [Abstract][Full Text] [Related]
32. Family studies of patients with reduced ristocetin aggregation and abnormalities of factor VIII and/or platelet function. Ekert H; Ananthakrishnan R; Muntz RH; Dowling S; D'Souza S Thromb Haemost; 1976 Aug; 36(1):78-85. PubMed ID: 1087478 [TBL] [Abstract][Full Text] [Related]
33. [Differential diagnosis of the functional disturbances of blood platelets. II. Extracorpuscular defects]. Kubisz P? Vnitr Lek; 1975 Oct; 21(10):992-8. PubMed ID: 1081300 [No Abstract] [Full Text] [Related]
34. 2B or not 2B? Masquerading as von Willebrand disease? Favaloro EJ; Koutts J J Thromb Haemost; 2012 Feb; 10(2):317-9. PubMed ID: 22145817 [No Abstract] [Full Text] [Related]
35. The clinical relevance of platelet aggregation study in myeloproliferative disorders. Kueh YK; Chan L; Lim BC; Suri R; Tan YO Ann Acad Med Singap; 1983 Jul; 12(3):466-71. PubMed ID: 6611104 [TBL] [Abstract][Full Text] [Related]
36. Platelet function in myeloproliferative disorders: characterization and sequential studies show multiple platelet abnormalities, and change with time. Baker RI; Manoharan A Eur J Haematol; 1988 Mar; 40(3):267-72. PubMed ID: 3356243 [TBL] [Abstract][Full Text] [Related]